[(2S,3S,4S,4aS,4bS,5R,6S,7S,8aS,10R,10aR)-7,10-diacetyloxy-5-benzoyloxy-2-ethenyl-3,6,10a-trihydroxy-2,4b,8,8-tetramethyl-1-oxo-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-4-yl] benzoate

Details

Top
Internal ID e435de09-0b82-42a9-ade6-f80cf42f1e6f
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Diterpenoids
IUPAC Name [(2S,3S,4S,4aS,4bS,5R,6S,7S,8aS,10R,10aR)-7,10-diacetyloxy-5-benzoyloxy-2-ethenyl-3,6,10a-trihydroxy-2,4b,8,8-tetramethyl-1-oxo-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-4-yl] benzoate
SMILES (Canonical) CC(=O)OC1CC2C(C(C(C(C2(C3C1(C(=O)C(C(C3OC(=O)C4=CC=CC=C4)O)(C)C=C)O)C)OC(=O)C5=CC=CC=C5)O)OC(=O)C)(C)C
SMILES (Isomeric) CC(=O)O[C@@H]1C[C@@H]2[C@@]([C@@H]3[C@@]1(C(=O)[C@@]([C@@H]([C@H]3OC(=O)C4=CC=CC=C4)O)(C)C=C)O)([C@H]([C@H]([C@H](C2(C)C)OC(=O)C)O)OC(=O)C5=CC=CC=C5)C
InChI InChI=1S/C38H44O12/c1-8-36(6)29(42)27(49-32(43)22-15-11-9-12-16-22)28-37(7)24(19-25(47-20(2)39)38(28,46)34(36)45)35(4,5)30(48-21(3)40)26(41)31(37)50-33(44)23-17-13-10-14-18-23/h8-18,24-31,41-42,46H,1,19H2,2-7H3/t24-,25+,26-,27-,28+,29+,30+,31-,36-,37-,38-/m0/s1
InChI Key UVLMOXBOUWFDIG-PQEFSWHNSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C38H44O12
Molecular Weight 692.70 g/mol
Exact Mass 692.28327683 g/mol
Topological Polar Surface Area (TPSA) 183.00 Ų
XlogP 4.30
Atomic LogP (AlogP) 3.21
H-Bond Acceptor 12
H-Bond Donor 3
Rotatable Bonds 7

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3S,4S,4aS,4bS,5R,6S,7S,8aS,10R,10aR)-7,10-diacetyloxy-5-benzoyloxy-2-ethenyl-3,6,10a-trihydroxy-2,4b,8,8-tetramethyl-1-oxo-4,4a,5,6,7,8a,9,10-octahydro-3H-phenanthren-4-yl] benzoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9881 98.81%
Caco-2 - 0.8204 82.04%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.5571 55.71%
Subcellular localzation Mitochondria 0.7627 76.27%
OATP2B1 inhibitior - 0.7126 71.26%
OATP1B1 inhibitior + 0.8636 86.36%
OATP1B3 inhibitior + 0.8260 82.60%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.9545 95.45%
P-glycoprotein inhibitior + 0.8225 82.25%
P-glycoprotein substrate - 0.6465 64.65%
CYP3A4 substrate + 0.6812 68.12%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8699 86.99%
CYP3A4 inhibition - 0.5999 59.99%
CYP2C9 inhibition - 0.8640 86.40%
CYP2C19 inhibition - 0.8823 88.23%
CYP2D6 inhibition - 0.9312 93.12%
CYP1A2 inhibition - 0.8078 80.78%
CYP2C8 inhibition + 0.7215 72.15%
CYP inhibitory promiscuity - 0.9342 93.42%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9343 93.43%
Carcinogenicity (trinary) Non-required 0.5822 58.22%
Eye corrosion - 0.9925 99.25%
Eye irritation - 0.8968 89.68%
Skin irritation - 0.7421 74.21%
Skin corrosion - 0.9394 93.94%
Ames mutagenesis - 0.6600 66.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6740 67.40%
Micronuclear - 0.5800 58.00%
Hepatotoxicity - 0.5625 56.25%
skin sensitisation - 0.6041 60.41%
Respiratory toxicity + 0.6667 66.67%
Reproductive toxicity + 0.7333 73.33%
Mitochondrial toxicity + 0.5750 57.50%
Nephrotoxicity + 0.5000 50.00%
Acute Oral Toxicity (c) III 0.6649 66.49%
Estrogen receptor binding + 0.7613 76.13%
Androgen receptor binding + 0.6632 66.32%
Thyroid receptor binding + 0.6472 64.72%
Glucocorticoid receptor binding + 0.7198 71.98%
Aromatase binding + 0.6066 60.66%
PPAR gamma + 0.7245 72.45%
Honey bee toxicity - 0.6933 69.33%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1951 P21397 Monoamine oxidase A 99.61% 91.49%
CHEMBL221 P23219 Cyclooxygenase-1 96.83% 90.17%
CHEMBL1293249 Q13887 Kruppel-like factor 5 96.12% 86.33%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.38% 91.11%
CHEMBL2581 P07339 Cathepsin D 94.76% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.49% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.20% 96.09%
CHEMBL4040 P28482 MAP kinase ERK2 92.19% 83.82%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 88.49% 99.23%
CHEMBL340 P08684 Cytochrome P450 3A4 87.20% 91.19%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 86.84% 91.07%
CHEMBL5608 Q16288 NT-3 growth factor receptor 86.09% 95.89%
CHEMBL5028 O14672 ADAM10 85.94% 97.50%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 85.82% 94.08%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 85.71% 95.50%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 83.90% 94.62%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 83.40% 83.00%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 81.08% 93.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.63% 89.00%
CHEMBL264 Q9Y5N1 Histamine H3 receptor 80.57% 91.43%

Cross-Links

Top
PubChem 44583688
NPASS NPC26033
ChEMBL CHEMBL508513
LOTUS LTS0061063
wikiData Q105279950